The peptide everyone asks about, inside real medicine.
Compounded BPC-157 sourced through a licensed US pharmacy and placed inside clinician review, not a research-vendor checkout.
Compounded by a licensed US pharmacy to an individual prescription. Compounded preparations are not FDA-approved drug products.
About 10 minutes. No charge unless your clinician approves.
Repair needs a way in.
Tendons and ligaments are difficult tissue to rebuild. Their limited blood supply means the cells, oxygen, and raw materials involved in repair have a harder time reaching the place they are needed.
BPC-157 is built around that problem.
It is a synthetic 15-amino-acid peptide modeled on a naturally occurring protective protein found in the stomach lining, one of the most demanding repair environments in the body. Researchers isolated the sequence now known as BPC-157 and have studied how it interacts with several parts of the tissue-repair process.
The findings are what made this peptide famous.
Research shows BPC-157 promotes new blood-vessel growth through VEGFR2, a signaling pathway your body uses in angiogenesis.1 In rat tendon and cultured tendon cells, BPC-157 increased the outgrowth, survival, and migration of the cells involved in rebuilding damaged tissue.2
That matters because repair is not one event. Tissue needs blood supply. Repair cells need to reach the site. And the environment has to support the work once they get there.
BPC-157 is one of the most studied and most requested peptides in the recovery conversation for a reason.
If you already know the molecule, the meaningful difference is what surrounds it: a licensed clinician, a licensed US pharmacy, and an individual prescription. Potential benefits stay tied to the research that reported them.
- Hsieh MJ, et al. Therapeutic potential of pro-angiogenic BPC157 is associated with… J Mol Med. 2017.
- Chang CH, et al. The promoting effect of pentadecapeptide BPC 157 on tendon healing… J Appl Physiol. 2011.
For the injuries that are technically over, but not forgotten.
The Accumulated Wear
Nothing is torn. Nothing is broken. But years of training, compensation, and small injuries have left connective tissue that keeps asking for more attention than the rest of you.
The Recovery That Plateaued
You did the rehab. You gave it time. Most of the progress came, and then the last part simply stopped moving. You know the difference between discomfort and a recovery that has stalled.
Cleared Is Not the Same as Rebuilt
The procedure is behind you and the surgeon has signed off. Now the work is about the tissue you still have to live, train, and move with every day.
Compounded BPC-157 is not an FDA-approved drug product. Whether it is appropriate for you is determined by a licensed provider from your full Assessment.
This might not be the right fit if:
- Active or suspected malignancy, or a history of cancer without oncology clearance
- Pregnancy or breastfeeding
- Known hypersensitivity to any component of the preparation
- Under 18
Your intake screens for all contraindications. Every candidate is evaluated by a licensed clinician before any prescription is issued. No prescription is issued without clearance.
BPC-157, prescribed with care.
Compounded by a licensed 503A pharmacy. Prescribed by a licensed provider after clinical review.
- An independent licensed provider reviews your full Assessment and gives you a real answer either way.
- Your injury, medical history, medications, and current recovery plan are considered together before anything is prescribed.
- If BPC-157 fits, your provider sets the dose and duration for you and adjusts the plan from your actual response.
- Provider review, the prescription if approved, pharmacy, and shipping handled inside one plan.
Compounded by a licensed US pharmacy to an individual prescription. Compounded preparations are not FDA-approved drug products.
*Price reflects a 3 month commitment. Other billing options are shown at checkout.
More in Recovery & Repair.
BPC-157 Oral
A capsule that meets the digestive tract directly.
Compounded oral BPC-157 delivered directly into the digestive tract, with a clinician deciding whether capsule or injection fits the case.
Wolverine Stack
Two repair pathways. One prescription.
A compounded BPC-157 and TB-500 prescription pairing BPC-157's tissue-repair signaling with thymosin beta-4 biology in cell movement and wound closure.
Wolverine 2.0
Add the inflammation layer.
A compounded three-peptide prescription that adds a distinct inflammation and comfort layer to the recovery conversation.
Do not use if you have
- Active or suspected malignancy
Commonly reported
- Mostly local — soreness, redness or swelling where you inject
Because BPC-157 acts on blood vessel formation, your provider screens carefully for any history of cancer. Human safety data is limited, which is the reason this sits with a clinician rather than in a shopping cart.
Asked and answered.
You are not charged, and you are not left guessing. Your clinician explains the reasoning and, where it helps, what a better path might look like. Reviews are typically completed in under 24 hours.
In July 2026 an FDA advisory committee voted to recommend BPC-157 for pharmacy compounding. That recommendation is advisory and the agency has not yet acted on it. No compounded medication is FDA-approved, including this one. Compounded medicines are made to your individual prescription by a licensed pharmacy rather than manufactured and approved as a finished drug product.
The honest answer depends on the tissue, the injury, and you. Your provider sets expectations from your history and adjusts the plan from what actually happens rather than promising a recovery calendar before treatment starts.
The difference is not the name on the vial. It is everything around it. Research chemicals are sold without a clinician deciding whether the compound belongs in your care, without a prescription prepared for you by a licensed pharmacy, and without a medical record connecting the medication to the person taking it. The FDA has found products sold this way under false labels, some naming compounding pharmacies that do not exist, and warns they “can pose risks of serious harm” by bypassing the body’s defenses.F4 Testing has found wide variation in purity and in how much of the compound is actually in the vial. With AnthologyRX+, a licensed provider reviews your history and a licensed US pharmacy fills your prescription. You are buying medical care around an interesting molecule, not a vial and a disclaimer.
Any time, before your renewal date. No phone calls required.
- FDA, Concerns with Unapproved GLP-1 Drugs Used for Weight Loss, and FDA Warning Letter to Gram Peptides, March 31, 2026.